Fibrolamellar Cancer Foundation AI policy
Disclosure requiredChecked November 9, 2026
In short
The Fibrolamellar Cancer Foundation permits grant applicants to use AI tools in developing proposals, but all AI use and how it was used must be disclosed in the application. Applicants are fully responsible for accuracy. Review committee members may not use AI tools to analyze, summarize, or interpret applications or to write critiques.
For applicants
- Applicants may use AI tools to develop proposals, but are fully responsible for the accuracy of the content and must disclose all use of AI and how it was used in the application.[1]
For reviewers
- Members of any FCF review committee, including scientific and community reviewers, may not use AI tools to analyze, summarize, or interpret information in a grant application or to formulate peer review critiques.[1]
Sources
- [1]AI Use Policy
Fibrolamellar Cancer Foundation, August 14, 2025
“Grant applicants are permitted to use AI Tools in the development of their proposals. However, applicants are fully responsible for the accuracy of the content of their proposals. All use of AI, and details about how it was used, must be disclosed in the application.”
“Therefore, members of any FCF review committee, including Scientific Reviewers and Community Reviewers, are not permitted to use AI Tools for analyzing, summarizing, or interpreting information provided in any grant application, or for formulating peer review critiques for grant applications.”
This page summarizes published guidance and is not legal advice. Policies change, and a specific solicitation can add its own rules, so confirm against the funding announcement before you apply. See every funder's AI policy.